Pharmaceutical Industry: Our clients

PricewaterhouseCoopers is the unchallenged global leader in providing professional services for firms from the pharmaceutical sector.

PricewaterhouseCoopers's share in auditing the world's top pharmaceutical companies

PricewaterhouseCoopers provides audit services to almost one-half of the 20 largest pharmaceutical companies in the world.

Source: Pharmaceutical Executive, May 2004

PricewaterhouseCoopers as auditor to the top pharmaceutical companies in Poland

Source: PricewaterhouseCoopers on IntelliNews, February 2005

We are also the lead auditor of pharmaceutical companies in Poland. We audit 11 of the 29 pharmaceutical companies which noted the largest sales in Poland in the first half of 2004.

Share of PricewaterhouseCoopers audit clients in sales of the pharmaceutical sector in Poland

It is worth emphasizing that the companies which we audit are the leaders of the pharmaceutical industry. The share of sales of our clients in the total sales of the pharmaceutical industry in Poland in the first half of 2004 (29 top firms excluding the hospital market) amounted to 44%.

Source: PricewaterhouseCoopers on IntelliNews, February 2005

Pharmaceutical companies also value PricewaterhouseCoopers' advisory services. Tax services, used by over 80% of the pharmaceutical companies in Poland, are particularly valued. We provide other advisory services to 75% of the top companies from the sector in Poland.

Our clients from the pharmaceutical and medical sector in Poland include the following companies:

	Abbott Laboratories Poland Sp. z o.o.

	ACP Pharma S.A.*

	Aesculap -Chifa Sp. z o.o.*

	ALTANA Pharma Sp. z.o.o.*

	AstraZeneca Pharma Poland Sp. z o.o.

	Aventis Pasteur Sp. z o.o.*

	Bayer Sp. z o.o.*

	Berlin-Chemie/Menarini Polska Sp. z o.o.*

	Boehringer Ingelheim Sp. z o.o.*

	Bolesławiecka Fabryka Materiałów Medycznych "Polfa" S.A.*

	Bristol-Myers Squibb Polska Sp. z o.o.*

	Cefarm Rzeszów S.A.*

	Cefarm Zielona Góra S.A.*

	Cefarm Śląski S.A.*

	Comesa Polska Sp. z o.o.*

	Eli Lilly Polska Sp. z o.o.

	Ferrosan Poland Sp. z o.o.*

	Gambro Poland Sp. z o.o.*

	GlaxoSmithKline Consumer Healthcare Sp. z o.o.*

	GlaxoSmithKline Pharmaceuticals S.A.*

	ICN Polfa Rzeszów S.A.*

	Janssen-Cilag Polska Sp. z o.o.*

	Johnson&Johnson Poland Sp. z o.o.*

	KRKA Polska Sp. z o.o.*

	Kutnowskie Zakłady Farmaceutyczne "Polfa" S.A.

	Lek Polska Sp. z o.o.*

	Lek S.A.*

	Merck Sharp & Dohme Idea S.A.*

	Merck Sp. z o.o.

	Novartis Poland Sp. z o.o.*

	Novo Nordisk Pharma Sp. z o.o.*

	Orfe S.A.*

	PLIVA Kraków, Zakłady Farmaceutyczne S.A.

	Polpharma S.A.

	Roche Polska Sp. z o.o.

	Sanofi Aventis *

	Schering Polska Sp. z o.o.

	Schering-Plough Central East S.A.

	Servier Polska Sp. z o.o.

	Super-Pharm Poland Sp. z o.o.*

	US Pharmacia Sp. z o.o.

	Vetoquinot Biowet Sp. z o.o.*

	Wyeth Sp. z o.o.*

	Yamanouchi Pharma Sp. z o.o

* indicates PricewaterhouseCoopers Sp. z o.o. audit clients

Wersja polska

Contact

Privacy Legal About Site Provider Email Webmaster Site Map RSS

© 2008 PricewaterhouseCoopers. All rights reserved. PricewaterhouseCoopers refers to the network of member firms of PricewaterhouseCoopers International Limited, each of which is a separate and independent legal entity.